The clinical and economic burden of chronic obstructive pulmonary disease in the USA
Anthony J Guarascio,1 Shauntá M Ray,1 Christopher K Finch,2,3 Timothy H Self21University of Tennessee College of Pharmacy, Knoxville, 2University of Tennessee College of Pharmacy, Memphis, TN, USA; 3Methodist University Hospital, Memphis, TN, USAAbstract: Chronic obstructive pulmonary dis...
Main Authors: | Guarascio AJ, Ray SM, Finch CK, Self TH |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-06-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/the-clinical-and-economic-burden-of-chronic-obstructive-pulmonary-dise-a13349 |
Similar Items
-
Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease
by: Woods JA, et al.
Published: (2014-05-01) -
Evaluation of the economic and social burden of chronic obstructive pulmonary disease (COPD)
by: Konstantin Tachkov, et al.
Published: (2017-07-01) -
The disease burden of chronic obstructive pulmonary disease in Greece
by: Kourlaba G, et al.
Published: (2016-09-01) -
Economic burden of chronic obstructive pulmonary disease in Morocco: a cost of illness study
by: Soumaya Benmaamar, et al.
Published: (2024-01-01) -
Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review
by: Iheanacho I, et al.
Published: (2020-02-01)